Recent

% | $
Quotes you view appear here for quick access.

Medivation, Inc. Message Board

  • stockgeniussss stockgeniussss Jun 5, 2013 10:53 AM Flag

    The Truth About MDVN

    1.Not-Profitable despite having only pipeline at maximum exposure to market
    2.Mgmt & insiders issue out tens of millions each quarter in stock options despite increasing losses and uncertainty. That is the equivalent of highschool principal getting a 10 million dollar bonus for having all his students flunk an exam.
    3. Competition from J&J "Creaming" MDVN and Xtandi market share continues to be on shakey ground with several competitors
    4.One of the highest P/E in the entire market and most expensive stocks to own with a uncertain future.
    5. Drugs like Xtandi from MDVN or Provenge from DNDN are inherently flawed, with the highest costs and the least effectiveness in preserving life. These drugs are less than innovative and will never be sustainable in the long run.
    6. MDVN has a poor deal in their AZN partnership, benefiting AZN more than MDVN. This leaves MDVN with a minority in share of their own product and AZN gets a majority of the sales. A good DD should evaluate the performance of the mgmt when doing such a one handed deal, seriously compromising their companies credibility and standing in the business world.

    Sentiment: Strong Sell

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
MDVN
60.31-1.17(-1.90%)May 26 4:00 PMEDT